Skip to main content

Currently Skimming:

Appendix A: Biographic Information on the Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing
Pages 72-75

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 72...
... . He is in mammalian and microbial process development, in- responsible for assessing and implementing technologies cluding expression vector design, cell-line selection and and infrastructure capabilities to accelerate the developscreening, GMP cell banking and characterization, genet- ment of CBRN medical countermeasures (MCM)
From page 73...
... Joyner is the continuous manufacturing program programmatic and technical leadership to implement plat- lead and the technical monitor for all contractor staff that form-based discovery, design, manufacturing, and testing specialize in small molecules, large molecules, and vactechnologies to streamline MCM development and reduce cines, technology transfers, manufacturing and product risk.
From page 74...
... She is responsible for technical qual- erologous production of the anticancer drug Taxol, and ity and coordination with NIIMBL, a NIST-sponsored has successfully produced gram-scale titers of the first Manufacturing USA Institute whose mission is to accel- cyclized precursor and performed enzymatic studies to erate biopharmaceutical manufacturing innovation in the reveal previously unknown bottlenecks and methods of United States. She is on detail from NIST's Material Mea- alleviating them.
From page 75...
... Dr. Yoon received his PhD in chemical engineering from McMaster University, Canada, and his MBA from Babson College.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.